Introduction {#s1}
============

During nervous system development, various instructive and repulsive signaling cues cooperatively direct neurons to form chemical synapses with their appropriate targets. Studies have identified some molecules and elucidated their downstream mechanisms that instruct synaptogenesis such as FGF, Ephrin/Eph, Ig-family of cell adhesion molecules (IgCAMs) and synaptic cell adhesion molecules (SynCAMs) ([@bib70]; [@bib71]; [@bib10]; [@bib9]; [@bib16]; [@bib34]; [@bib77]; [@bib88]). Several axon guidance cues and their receptors also play critical roles to inhibit synapse formation ([@bib32]; [@bib36]; [@bib65]). Semaphorins (Sema) and their receptors, Plexins, are two conserved families of molecules that have a well-established function to repel axons during development ([@bib37], [@bib38]; [@bib51]; [@bib79]) and play prominent roles contributing to immune system, cardiovascular development and cancer regulation ([@bib15]; [@bib53]; [@bib75]).

In addition to its function as a long-range axon guidance cue during neuronal development, Sema/Plexin signaling plays a critical role as a negative regulator of synapse formation. The role of Sema/Plexin signaling to inhibit synapse formation was first observed in Drosophila, where ectopic expression of Sema2a causes elimination of specific neuromuscular junctions ([@bib44]). In mammals, Sema3E/PlexinD1 specifies sensory-motor connections ([@bib61]). Secreted Sema3F locally inhibits spine development through its receptors PlexinA3 and Neuropilin-2 in hippocampal granule cells ([@bib80]). Sema5A/PlexinA2 signaling inhibits excitatory synapse formation in dentate granule cells ([@bib13]). Sema5B diminishes synaptic connections in cultured hippocampal neurons ([@bib57]). However, little is known about the intracellular mechanisms through which Sema/Plexin signaling inhibits synapse formation.

The cytoplasmic domain of Plexin contains a GAP (GTPase-activating protein) domain that inactivates small GTPases ([@bib59]; [@bib67]). Upon activation by Semaphorins, Plexins repel axon outgrowth by inhibiting R-Ras ([@bib52]; [@bib29]; [@bib76]). Recent biochemical and structural analyses demonstrated that the GAP domain of mammalian PlexinA3 is specific for Rap GTPases, which belong to the Ras family of GTPases and regulate the actin cytoskeleton ([@bib82], [@bib83]). PlexinA3 dimerization by Semaphorin activates its GAP domain, thereby inhibiting Rap1 from inducing neurite retraction. Drosophila PlexA and zebrafish PlexinA1 promote remodeling of epithelial cells by inhibiting Rap1 GTPase during wound healing ([@bib90]). Another Rap GTPase, Rap2, can inhibit neurite outgrowth ([@bib33]). Similar to Sema/Plexin signaling, Rap GTPases regulate synapse formation and function. Rap2 negatively regulate spine number in cultured hippocampal neurons ([@bib20]). Rap1 and Rap2 regulate synaptic activity by removing AMPA receptors from spines during long-term depression and depotentiation, respectively ([@bib91], [@bib92]). While the GAP domain of Plexin is critical to inhibit synapse formation ([@bib13]; [@bib46]), we still do not know whether Plexin regulates synapse patterning via Rap GTPases at presynaptic sites.

In *Caenorhabditis elegans*, Sema/Plexin signaling functions in vulva formation and male ray development ([@bib11], [@bib12]; [@bib21]; [@bib31]; [@bib41]; [@bib50]; [@bib55], [@bib56]). Using this model system, we previously reported that Sema/Plexin signaling in the nervous system mediates a critical inter-axonal interaction for the tiled synaptic innervation of two DA-class cholinergic motor neurons (DA8 and DA9) ([@bib46]). Cell bodies of nine DA neurons in *C. elegans* reside in the ventral nerve cord, sending dendrites ventrally and axons dorsally to form *en passant* synapses onto the dorsal body wall muscles. Even though axons of DA neurons show significant overlap, each motor neuron forms synapses onto muscles within specific sub-axonal domains, which do not overlap with those from neighboring DA neurons. This unique synaptic innervation creates tiled synaptic patterns along the nerve cord ([@bib85]).

Tiled synaptic innervation occurs within most motor neuron classes and may contribute to the sinusoidal locomotion pattern of *C. elegans* ([@bib85]). Using a combination of two fluorescent proteins (GFP and mCherry) fused with the presynaptic vesicle protein, RAB-3, and two tissue specific promoters ([Figure 1](#fig1){ref-type="fig"}) ([@bib46]), we can visualize this synaptic tiling between DA8 and DA9 neurons. We reported that PLX-1 localizes at the anterior edge of the DA9 synaptic domain in axon-axon interactions in a Semaphorin-dependent manner, where it locally inhibits formation of the presynaptic specialization via its GAP domain. Loss of *Semas* or *plx-1* causes anterior expansion of DA9 synaptic domain and posterior expansion of DA8 synaptic domain. This result indicates loss of inter-axonal interactions between DA8 and DA9 neurons. Consistently, Tran et al., also observed excess dendritic spine formation, specifically within the region close to the cell body, in the *plexin* knockout mouse ([@bib80]). These findings suggest a conserved mechanism by which Sema/Plexin locally inhibits synapse formation.

![Gain- and loss-of-function *rap-2* mutants show synaptic tiling defects.\
(**A** and **B**) Representative image of synaptic tiling of wild type (**A**) and *plx-1* mutant (**B**) animals. Images show *wyIs446* marker to label synapses in DA8 (GFP::RAB-3) and DA9 (GFP::RAB-3+mCherry::RAB-3). Dotted box represents the magnified images from A and B of the synaptic tiling border. Schematics of DA8 (green) and DA9 (magenta) neurons with parameters for analysis shown on the right. (**C--F**) Representative images of *wyIs446* strains with the following genotypes: *rap-2(G12V)* overexpression in DA neurons (**C**), *rap-2 G12V (miz18)* (**D**), *rap-2 null (gk11)* (**E**) and *rap-2 S17A (miz19)* (**F**). Synaptic domains from DA8 and DA9 are highlighted with green and magenta lines, respectively. Asterisks: DA9 cell body. Arrows: dorsal commissure of DA9. Scale bars: 20 μm. (**G**) Quantification of overlap between DA8 and DA9 synaptic domains. Each dot represents a single animal. Blue bars indicate mean ± SEM. n.s.: not significant; \*\*\*p\<0.001.](elife-38801-fig1){#fig1}

We previously reported that *let-60/KRas* gain-of-function mutants showed very mild synaptic tiling defects. Since mammalian Plexin acts as a RapGAP, we hypothesized that Rap GTPase is the major downstream effector of PLX-1 to regulate synaptic tiling of DA neurons. Here, we report that *rap-2*, a *C. elegans* ortholog of human Rap2A, and its effector kinase *mig-15* (TNIK: Traf2- and Nck-interacting kinase) act genetically downstream of *plx-1* to regulate synaptic tiling. PLX-1 delineates the border of synaptic tiling by locally inhibiting RAP-2 along the DA9 axon. We also discovered an unexpected role for *mig-15* in inhibiting synapse formation. Our results reveal the mechanism underlying Plexin signaling to form fine synaptic map connectivity.

Results {#s2}
=======

*rap-2* functions downstream of *plx-1* to regulate synaptic tiling {#s2-1}
-------------------------------------------------------------------

Three Rap genes exist in the *C. elegans* genome (*rap-1*, *rap-2* and *rap-3*). To delineate which Rap GTPase functions downstream of PLX-1 in synaptic tiling between DA8 and DA9 neurons, we first examined the expression patterns of all three *rap* genes ([Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}). Among them, only *rap-2*, an ortholog of mammalian Rap2a, was expressed in motor neurons including DA8 and DA9, while *rap-1* and *rap-3* were not expressed in these cells ([Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}). In wild type animals, synaptic domains of DA8 and DA9 neurons did not show significant overlap, creating tiled synaptic innervation ([Figure 1A and G](#fig1){ref-type="fig"}). In the *plx-1(nc36)* null mutant, synaptic domains of DA8 and DA9 expanded posteriorly and anteriorly, respectively. As a result, synaptic domains of these neurons overlapped significantly ([Figure 1B and G](#fig1){ref-type="fig"}).

Since the intracellular domain of Plexin contains a RapGAP domain, we hypothesized that RAP-2 preferentially exists in a GTP-bound form in the *plx-1* mutants. The G12V mutant is widely used as a constitutively GTP-form of small GTPases including mammalian Rap2A and *C. elegans* RAP-1 ([@bib33]; [@bib62]). Expression of a constitutively GTP-bound form of *rap-2(G12V)* under the A-type neuron specific promoter, P*unc-4*, elicited a similar synaptic tiling defect as *plx-1* mutants ([Figure 1C and G](#fig1){ref-type="fig"}). Expression of wild type *rap-2* under the *unc-4* promoter did not affect the synaptic tiling pattern, suggesting that G12V mutation but not over-expression of *rap-2* caused the synaptic tiling defect ([Figure 1G](#fig1){ref-type="fig"}). We then generated *rap-2(G12V)* mutants using CRISPR/Cas9 genome editing. We observed the same synaptic tiling defects in three independent *rap-2(G12V)* mutant alleles (*miz16, miz17* and *miz18*) as in *plx-1* mutants ([Figure 1D and G](#fig1){ref-type="fig"} and [Figure 1---figure supplement 2](#fig1s2){ref-type="fig"}). We found a comparable level of gene expression among all three *rap-2(G12V)* mutants to wild type *rap-2* using RT-qPCR ([Figure 1---figure supplement 2](#fig1s2){ref-type="fig"}). These results confirm that the *rap-2(G12V)* mutation itself, not changes in gene expression, underlie the synaptic tiling defect in *rap-2(G12V)* mutants.

Surprisingly, the null mutant of *rap-2(gk11)* also showed the same synaptic tiling defect, as did the constitutively GTP-form of *rap-2(G12V)* mutants ([Figure 1E and G](#fig1){ref-type="fig"}). This result suggests that synaptic tiling requires both the GTP- and GDP-bound forms of RAP-2. Indeed, the constitutively GDP-bound form of *rap-2* mutants (S17A: *miz19, miz20*) showed the identical synaptic tiling defect as *rap-2(G12V)* and *rap-2(gk11)* mutants ([Figure 1F and G](#fig1){ref-type="fig"} and [Figure 1---figure supplement 2](#fig1s2){ref-type="fig"}). These results suggest that the cycling between GTP- and GDP-forms of RAP-2 is critical to regulate the spatial patterning of synapses.

Similar to *plx-1* mutants, the synaptic tiling defect in all *rap-2* mutants is caused by both the posterior expansion of DA8 synaptic domain and the anterior expansion of the DA9 synaptic domain ([Figure 1---figure supplement 2](#fig1s2){ref-type="fig"}). However, none of *rap-2(G12V), rap-2(S17A)* and *rap-2(gk11)* mutants enhanced or suppressed the synaptic tiling defect in *plx-1* mutants ([Figure 1G](#fig1){ref-type="fig"}). These results suggest that *plx-1* and *rap-2* function in the same genetic pathway. Consistent with the expression patterns of *rap-1* and *rap-*3, neither *rap-1(pk2082)* nor *rap-3(gk3975)* null mutants showed significant synaptic tiling defects by themselves and did not enhance the synaptic tiling defect in *rap-2(gk11)* null mutants ([Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}). All mCherry::RAB-3 puncta co-localized with active zone markers, CLA-1 ([@bib87]) and UNC-10/Rim ([@bib86]) in the DA9 neurons of *plx-1(nc36)* and *rap-2(gk11)* mutants, suggesting that RAB-3 puncta represent *bona fide* synapses ([Figure 1---figure supplement 3](#fig1s3){ref-type="fig"}). Taken together, these data indicate that *plx-1* and *rap-2* act in the same genetic pathway for synaptic tiling in DA neurons.

RAP-2 functions cell autonomously in DA neurons {#s2-2}
-----------------------------------------------

We next determined the cellular location for *rap-2* function. Since *rap-2(gk11)* null mutants showed a synaptic tiling defect, we conducted tissue specific rescue experiments using tissue-specific promoters as previously described ([@bib46]). Expression of *rap-2* in the post-synaptic body wall muscle cells under the *hlh-1* promoter or in another class of cholinergic motor neurons in the dorsal nerve cord (DB neurons) under the truncated *unc-129* promoter did not rescue the synaptic tiling defect in *rap-2(gk11)* animals ([Figure 2A, B and G](#fig2){ref-type="fig"}). However, DA neuron-specific expression using the *unc-4c* promoter strongly rescued the synaptic tiling defect ([Figure 2C and G](#fig2){ref-type="fig"}). DA9-specific expression of *rap-2* under the *mig-13* promoter partially rescued the synaptic tiling defect ([Figure 2E and G](#fig2){ref-type="fig"}). DA9-specific expression of *rap-2* rescued the phenotype of anterior expansion of the DA9 synaptic domain but not the posterior expansion of DA8 synaptic domain ([Figure 2H and I](#fig2){ref-type="fig"}). These results suggest that *rap-*2 regulates synapse patterning in a cell-autonomous manner. In contrast to the DA9-specific rescue experiment in *rap-2* mutants, DA9-specific expression of *plx-1* cDNA was sufficient to rescue synaptic defects in both DA9 and DA8 ([@bib46]) (see Discussion).

![*rap-2* functions in DA neurons.\
(**A--F**) Representative images of *rap-2; wyIs446* animals expressing *Phlh-1::rap-2* (**A**), *Punc-129::rap-2* (**B**), *Punc-4c::rap-2* (**C**), *Punc-4c::Rap2a (human)* (**D**), *Pmig-13::rap-2* (**E**) and *Punc-4c;;rap-1* (**F**). Synaptic domains of DA8 and DA9 are highlighted with green and magenta lines, respectively. Asterisks: DA9 cell body. Arrows: dorsal commissure of DA9. Scale bars: 20 μm. (**G--I**) Quantification of DA8/DA9 overlap (**G**), DA9 synaptic domain (**H**) and DA8 asynaptic domain (**I**). Each dot represents a single animal. Blue bars indicate mean ± SEM. n.s.: not significant; \*\*\*p\<0.001; \*\*p\<0.01; \*p\<0.05.](elife-38801-fig2){#fig2}

We also observed that expression of human Rap2a in DA neurons rescued the synaptic tiling defect of *rap-2* mutants, suggesting the function of *rap-2* in synapse patterning is conserved across species ([Figure 2D and G](#fig2){ref-type="fig"}). Previous work suggested a partial functional redundancy between *rap-1* and *rap-*2 in *C. elegans* ([@bib62]). However, we found that *rap-1* expression in DA neurons did not rescue the synaptic tiling defect of *rap-2* mutants, suggesting functional diversity between *rap-1* and *rap-*2 ([Figure 2F and G](#fig2){ref-type="fig"}). Taken together, we conclude that *rap-2* functions cell autonomously in DA neurons to regulate synaptic tiling.

RAP-2 activity is spatially regulated by PLX-1 {#s2-3}
----------------------------------------------

Previously, we demonstrated that PLX-1::GFP is localized at the anterior edge of the DA9 synaptic domain, where it negatively regulates synapse formation through its cytoplasmic GAP domain ([Figure 3A and E](#fig3){ref-type="fig"}) ([@bib46]). In the *rap-2(gk11)* mutant background, we observed no change in PLX-1::GFP localization but did observe ectopic synapses in the axonal region anterior to the PLX-1::GFP domain ([Figure 3B and F](#fig3){ref-type="fig"}). This result is consistent with our hypothesis that *rap-2* acts downstream of *plx-1* to regulate synaptic tiling. Together with our finding that synaptic tiling requires both GTP- and GDP-bound forms of RAP-2, we speculate that PLX-1 acting at the anterior edge of the DA9 synaptic domain regulates the spatial activity of RAP-2 along the axon.

![PLX-1::GFP localization is not affected in *rap-2* and *mig-15* mutants.\
(**A--D**) Representative image of PLX-1::GFP alone (top) and PLX-1::GFP with mCherry::RAB-3 (middle) labeled with *wyIs320* in DA9 of wildtype (**A**), *rap-2 (gk11)* (**B**) and *mig-15(rh148)* (**C**). Bracket indicates the PLX-1::GFP patch localized at the anterior edge of the DA9 synaptic domain. Arrowheads indicate ectopic synapses formed anterior to the PLX-1::GFP patch. Scale bars: 20 μm. (**E--G**) Quantification of the normalized mCherry::RAB-3 signal (magenta) and PLX-1::GFP signal (green) in the dorsal axon of DA9 in wildtype (**E**), *rap-2 (gk11)* (**F**) and *mig-15(rh148)* (**G**). Animal were aligned according to the PLX-1::GFP patch at the anterior edge of the DA9 synaptic domain (orange arrow). Light colors indicate SEM.](elife-38801-fig3){#fig3}

We then sought to determine the spatial distribution of GTP-RAP-2 in DA9 axon. We conducted Fluorescence Lifetime Imaging Microscopy (FLIM)-based FRET (Förster Resonance Energy Transfer) measurements using EGFP-Rap2A (human) and mRFP-RalGDS(RBD: Ras Binding Domain)-mRFP ([@bib89]). As RalGDS-RBD specifically binds to GTP-Rap2 but not GDP-Rap2 ([@bib58]), FRET from EGFP-Rap2A to mRFP-RalGDS(RBD)-mRFP can be used as a readout of Rap2 activity. We detected FRET signal as a change of GFP fluorescence lifetime ([Figure 4A](#fig4){ref-type="fig"}). In HeLa cells, we observed a shorter lifetime of constitutively bound GTP construct EGFP-Rap2A(G12V) compared to GDP-bound EGFP-Rap2A(S17A), indicating that the FRET sensor can detect the nucleotide state of Rap2A ([Figure 4B and C](#fig4){ref-type="fig"}). Due to the low expression of *C. elegans* RAP-2 constructs in HeLa cells, we were not able to test whether the mammalian FRET sensor can detect *C. elegans* RAP-2 activity (data not shown).

![PLX-1 locally inhibits Rap2 activity in DA9.\
(**A**) Schematic of Rap2 FRET sensor system. Binding of mRFP- RalGDS(RBD)-mRFP to EGFP-Rap2 induces FRET from EGFP to mRFP, leading to decreased EGFP fluorescence lifetime. (**B**) Representative fluorescence (top) and fluorescence lifetime images (bottom) of HeLa cells expressing Rap2 FRET sensor (mRFP-RalGDS(RBD)-mRFP) with either constitutively GTP(G12V)- or GDP(S17A)- forms of human Rap2A. (**C**) Quantification of the binding fraction of Rap2 mutants in HeLa cells. Binding fractions measured from fluorescence decay curves of individual cells (G12V, n = 25; S17A, n = 25), as described previously ([@bib49]). Data shown as mean ± SEM. Asterisks denote statistical significance (p\<0.05, student's t-test). (**D**) Representative images of fluorescence lifetime (top) and fluorescence (bottom) of *mizIs19* in wild type (left) and *plx-1* mutants (right). White arrowheads indicate the position of the putative synaptic tiling border, as judged by the slight dorsal shift of the DA9 axon, as reported previously ([@bib46]). (**E**) Representative images of fluorescence lifetime (top) and fluorescence (bottom) of *mizIs19* in *unc-104* (left) and *unc-104; plx-1* double mutants (right). (**F**) Quantification of the difference in binding fraction of GTP-Rap2a and RalGDS(RBD) between synaptic region (dotted boxes in **D**) and anterior asynaptic region (solid boxes in **D**). The binding fraction measured in synaptic region (dotted rectangle) was subtracted by that in non-synaptic region (solid rectangle). Five micrometers along the axon line from the synaptic tiling border were used for quantification. Data presented as mean ± SEM (wild type, n = 22; *plx-1*, n = 17). (**G**) Quantification of the difference in binding fraction of GTP-Rap2A and RalGDS(RBD) between synaptic region (dotted boxes in **E**) and anterior asynaptic region (solid boxes in **E**). The binding fraction measured in synaptic region (dotted rectangle) subtracted from that in non-synaptic region (solid rectangle). Five micrometers along the axon line from the synaptic tiling border were used for quantification. Data are presented as mean ± SEM (*unc-104*, n = 21; *unc-104; plx-1*, n = 23). (**H**) Quantification of the difference in binding fraction of GTP-Rap2a and RalGDS(RBD) between synaptic region and anterior asynaptic region in *plx-1* mutants and *plx-1* mutants expressing rescuing constructs. Five micrometers along the axon line from the synaptic tiling border were used for quantification. Data are presented as mean ± SEM (*no array,* n = 35; *Ex\[Pmig-13::plx-1(RA)\], n = 39; Ex\[Pmig-13::plx-1(Δsema)\],* n = 41; *Ex\[Pmig-13::plx-1\],* n = 51).](elife-38801-fig4){#fig4}

We then expressed EGFP-Rap2A and mRFP-RalGDS(RBD)-mRFP FRET sensors in DA9 neurons in *C. elegans*. As human Rap2a rescued the synaptic tiling defect of *rap-2(gk11)* mutants ([Figure 2G](#fig2){ref-type="fig"}), we reasoned that the activity pattern of human Rap2A should recapitulate that of endogenous RAP-2. We indeed observed lower Rap2A activity at the anterior edge of the DA9 synaptic domain compared to within the synaptic domain ([Figure 4D and F](#fig4){ref-type="fig"}). This observation is consistent with the localization of PLX-1::GFP at the anterior edge of DA9 synaptic domain ([Figure 3A](#fig3){ref-type="fig"}) ([@bib46]). Local inhibition of Rap2a activity was strongly diminished in the *plx-1* mutant background ([Figure 4D and F](#fig4){ref-type="fig"}). Higher Rap2 activity in the synaptic region could simply indicate the presence of synapses within the synaptic domain, rather than Rap2 inactivation by Plexin at the anterior edge of the synaptic domain. To exclude this possibility, we examined Rap2 activity in *unc-104/Kif1A* mutants, which show no synapses are formed in DA9 axon ([@bib60]). We showed previously that PLX-1::GFP localization to the synaptic tiling border was independent of synapses, since it was unaffected in *unc-104/Kif1A* mutants ([@bib46]). In *unc-104* mutants, we observed the same local inhibition of Rap2A activity at the putative synaptic tiling border, but not in *unc-104; plx-1* double mutants ([Figure 4E and G](#fig4){ref-type="fig"}), indicating that Plexin controls local Rap2 activity independent of synapses.

To understand that this local Rap2 inactivation at the synaptic tiling border depends on the localized RapGAP activity of PLX-1, we examined the rescue activity of two PLX-1 mutant constructs, PLX-1(RA) and PLX-1(ΔSema), neither of which rescued the synaptic tiling defect of *plx-1* mutants ([@bib46]). PLX-1(RA) is a GAP-deficient mutant but localizes normally at the anterior edge of the DA9 synaptic domain. PLX-1(ΔSema) contains intact GAP domain but cannot be activated by the endogenous ligand and shows diffused localization due to deletion of the extracellular SEMA domain ([@bib46]). We observed no local Rap2 inactivation in *plx-1* mutant animals expressing these mutant PLX-1 constructs in DA9, while expression of wild type PLX-1 cDNA rescued local Rap2 inactivation at the anterior edge of the DA9 synaptic domain ([Figure 4H](#fig4){ref-type="fig"}).

While we do not fully exclude the possibility that PLX-1 indirectly regulates local Rap2 activity, these data taken together with the biochemical evidence that mammalian Plexin acts as RapGAP ([@bib83], [@bib82]) strongly suggests that Plexin localized at the anterior edge of the DA9 synaptic domain locally inactivates Rap2 GTPase to delineate the synaptic tiling border in DA9.

*mig-15*(*TNIK*) regulates synaptic tiling {#s2-4}
------------------------------------------

In mammals, TNIK (Traf2 and Nck1-interacting kinase) acts with Rap2 to regulate neurite extension, AMPA receptor trafficking in hippocampal neurons and microvilli formation in intestinal cells ([@bib30]; [@bib33]; [@bib27]). In *C. elegans*, *mig-15* is the sole ortholog of mammalian TNIK and its paralog MINK1 (Misshapen-like kinase 1), which also is an effector of Rap GTPase ([@bib54] ). *mig-15* can regulate various cellular processes, such as axon guidance and cell migration ([@bib5]; [@bib63]; [@bib69]; [@bib78]). We found that *mig-15(rh148)* hypomorphic mutants showed a severe synaptic tiling defect ([Figure 5A and D](#fig5){ref-type="fig"}). Similar to *plx-1* and *rap-2* mutants, the synaptic tiling defect followed the anterior expansion of the DA9 synaptic domain and the posterior expansion of the DA8 synaptic domain ([Figure 5E and F](#fig5){ref-type="fig"}). All RAB-3 puncta in *mig-15(rh148)* mutants co-localized with active zone markers, CLA-1 and UNC-10 ([Figure 1---figure supplement 3](#fig1s3){ref-type="fig"}), suggesting that these RAB-3 puncta represent bona fide synapses. We observed axon guidance defects (23%, n = 100) or ectopic branch formation (56%, n = 100) in DA9 of *mig-15* mutant animals ([Figure 5---figure supplement 1](#fig5s1){ref-type="fig"}). These were excluded from our analysis of synaptic tiling phenotypes. While only half of the *mig-15* mutant animals showed axon guidance defects or ectopic branch formation, the synaptic tiling defect of *mig-15* mutants was almost fully penetrant ([Figure 5D](#fig5){ref-type="fig"}). We did not observe significant synaptic tiling defects in *cdh-4(rh310)* mutants (DA8/DA9 overlap: 4.6 ± 1.02 μm, n = 21), which can exhibit an axon defasciculation phenotype in the dorsal nerve cord neurons ([@bib68]). These data suggest that the synaptic tiling defect in the *mig-15* mutants is not a secondary effect of axon outgrowth and guidance.

![*mig-15(TNIK)* mutants show a severe synaptic tiling defect.\
(**A--C**) Representative images of synaptic tiling marker (*wyIs446*) in *mig-15(rh148)* (**A**), *rap-2(gk11); mig-15(rh148)* (**B**) and *plx-1(nc36); mig-15(rh148)* (**C**) mutants. Synaptic domains of DA8 and DA9 are highlighted with green and magenta lines, respectively. Asterisks: DA9 cell body. Arrows: dorsal commissure of DA9. Scale bars: 20 μm. (**D--F**) Quantification of overlap between DA8 and DA9 synaptic domains (**D**), DA9 synaptic domain (**E**) and DA8 asynaptic domain (**F**) in respective mutant backgrounds. Each dot represents measurement from a single animal. Blue bars indicate mean ± SEM. n.s.: not significant; \*\*\*p\<0.001.](elife-38801-fig5){#fig5}

The other two nonsense alleles (*rh326: Q439Stop*, *rh80: W898Stop*) also showed identical synaptic tiling defects as *mig-15(rh148)* ([Figure 5---figure supplement 2](#fig5s2){ref-type="fig"}). *mig-15(rh80)* has a nonsense mutation within the highly conserved CNH (citron/NIK homology) domain, which is required to interact with Rap2 in both mammals and *C. elegans* ([@bib74]). This suggests a physical interaction between RAP-2 and MIG-15 for synaptic tiling. *plx-1* or *rap-2* mutants did not enhance the synaptic tiling defect in *mig-15* mutants ([Figure 5B--F](#fig5){ref-type="fig"}). This result is consistent with our hypothesis that *mig-15* acts in the same genetic pathway as *plx-1* and *rap-2*. The PLX-1::GFP patch at the putative synaptic tiling border was unaffected in *mig-15* mutants, even though the position of the PLX-1::GFP patch has shifted slightly posteriorly compared with wild type ([Figure 3C and G](#fig3){ref-type="fig"}). Taken together, these results suggest that *mig-15* acts downstream of *plx-1* to regulate synaptic tiling.

Interestingly, the degree of overlap between DA8 and DA9 synaptic domains was even larger in *mig-15* mutants than those observed in *plx-1* and *rap-2* mutants (compare [Figures 1G](#fig1){ref-type="fig"} and [5D](#fig5){ref-type="fig"}), suggesting that *mig-15* also acts downstream of additional signaling pathways (see discussion).

*mig-15* functions in DA neurons {#s2-5}
--------------------------------

We then determined in which cells *mig-15* functions by conducting tissue specific rescue experiments. Since several *mig-15* isoforms (wormbase and data not shown) exist, we used the *mig-15* genomic sequence for the rescue experiments. Expression of *mig-15* under the DA neuron specific promoter (*Punc-4c*) strongly rescued the synaptic tiling defect of *mig-15(rh148)* mutants ([Figure 6A and F](#fig6){ref-type="fig"}), consistent with our hypothesis that *mig-15* acts in the same genetic pathway as *plx-1* and *rap-2*.

![*mig-15* functions in DA neurons.\
(**A--D**) Representative images of synaptic tiling marker (*wyIs446*) in the following backgrounds: *mig-15(rh148); Ex\[Punc-4c::mig-15\]* (**A**), *mig-15(rh148); Ex\[Pmig-13::mig-15\]* (**B**), wild type (**C**) and wild type animals expressing dominant-negative *mig-15(K50A)* in DA neurons (**D**). Synaptic domains of DA8 and DA9 are highlighted with green and magenta lines, respectively. Asterisks: DA9 cell body. Arrows: dorsal commissure of DA9. Scale bars: 20 μm. (**E**) Amino acid alignment of amino-terminal region of MIG-15 and TNIK. A kinase-dead mutation in TNIK (K54A) and corresponding mutation in MIG-15 (K50A) are highlighted in red. (**F--I**) Quantification of overlap between DA8 and DA9 synaptic domains (**F** and **I**), DA9 synaptic domain (**G**), DA8 asynaptic domain (**H**) in respective mutant backgrounds. Each dot represents measurements from a single animal. Blue bars indicate mean ± SEM. n.s.: not significant; \*\*\*p\<0.001; \*p\<0.05.](elife-38801-fig6){#fig6}

Expression of *mig-15* in both DA8 and DA9 rescued both posterior expansion of the DA8 synaptic domain and anterior expansion of the DA9 synaptic domain ([Figure 6G and H](#fig6){ref-type="fig"}). DA9 specific expression of *mig-15* under the *mig-13* promoter rescued anterior expansion of the DA9 synaptic domain, suggesting that *mig-15* functions cell autonomously in DA9 ([Figure 6B and G](#fig6){ref-type="fig"}). We observed that P*mig-13::mig-15* weakly rescued the posterior expansion of the DA8 synaptic domain ([Figure 6H](#fig6){ref-type="fig"}). This is likely due to the leaky expression of *mig-15* in DA8, as the *mig-15* genomic fragment without promoter showed slight rescue of the synaptic tiling defect in *mig-15(rh148)* mutants ([Figure 6F](#fig6){ref-type="fig"}). Kinase dead TNIK mutants act as a dominant-negative ([@bib43]). In DA neurons, expression of mutant *mig-15(kd)*, which carries the same mutation at the corresponding amino acid of the dominant-negative TNIK ([Figure 6E](#fig6){ref-type="fig"}), in DA neurons caused a severe synaptic tiling defect ([Figure 6C, D and I](#fig6){ref-type="fig"}). Based on these results, we conclude that *mig-15* functions cell autonomously in DA neurons.

*mig-15* inhibits synapse formation {#s2-6}
-----------------------------------

We observed that DA9-specific expression of *mig-15* under the *mig-13* promoter in *mig-15* mutants often exhibited a shorter synaptic domain compared to wild type ([Figure 6B and G](#fig6){ref-type="fig"}). So, we speculated that an excess amount of *mig-15* inhibits synapse formation. We tested the effect of *mig-15* overexpression in the wild type background. Strikingly, DA9-specific *mig-15* overexpression in wild type (*mig-15(OE)*) significantly reduced synapse number compared to wild type ([Figure 7A, C and D](#fig7){ref-type="fig"} and [Figure 7---figure supplement 1](#fig7s1){ref-type="fig"}). This reduction occurred without affecting the overall morphology of the DA9 neuron ([Figure 5---figure supplement 1](#fig5s1){ref-type="fig"}). Conversely, DA9 synapse number was significantly increased in the *mig-15(rh148)* mutants ([Figure 7B and D](#fig7){ref-type="fig"} and [Figure 7---figure supplement 1](#fig7s1){ref-type="fig"}). *mig-15* overexpression also significantly reduced synapse number in DD-type GABAergic motor neurons ([Figure 7---figure supplement 2](#fig7s2){ref-type="fig"}). These results indicate that *mig-15* is a negative regulator of synapse formation. Further, pan-neuronal expression of *mig-15* under the *rab-3* promoter caused severe uncoordinated locomotion in wildtype animals ([Figure 7---figure supplement 3](#fig7s3){ref-type="fig"}). These locomotor defects occurred concomitant with significantly reduced GFP::RAB-3 intensity in the dorsal nerve cord in *mig-15* over-expressing animals and without causing significant axon guidance defects ([Figure 7---figure supplement 3](#fig7s3){ref-type="fig"}). Taken together, these data indicate that reduced synapse number by *mig-15* overexpression disrupted proper functioning of the motor circuit. Importantly, we observed no significant increase in synapse numbers in *plx-1* or *rap-2* mutants ([Figure 7---figure supplement 1](#fig7s1){ref-type="fig"}), suggesting that the role of *mig-15* in negatively regulating synapse number is independent of its role in PLX-1/RAP-2 -mediated synaptic tiling ([Figure 8G](#fig8){ref-type="fig"}).

![*mig-15* negatively regulates synapse number.\
(**A--C**) Representative images of DA9 presynaptic marker, GFP::RAB-3 (*wyIs85*), in wild type (**A**), *mig-15(rh148)* (**B**) and *mig-15* overexpressing animals (**C**). Brackets represent DA9 synaptic domain. Asterisks: DA9 cell body. Arrows: dorsal commissure of DA9. Scale bars: 20 μm. (**D**) Quantification of DA9 synapse number. Each dot represents measurements from a single animal. Blue bars indicate mean ± SEM. n.s.: not significant; \*\*\*p\<0.001; \*p\<0.05. (**E--H**) Representative images of synaptic branched F-actin labeled with GFP::ut-CH (*wyIs329*) in wild type (**E**), *rap-2(gk11)* (**F**), *mig-15(rh148)* (**G**) and *mig-15* overexpressing animals (**H**). (**I**) Quantification of the length of GFP::ut-CH. Distance from the dorsal commissure to the most anterior and brightest GFP spot was measured. Blue bars indicate mean ± SEM. n.s.: not significant; \*\*\*p\<0.001; \*\*p\<0.01, \*p\<0.05.](elife-38801-fig7){#fig7}

![PLX-1/RAP-2 signaling coordinates synapse number and synaptic tiling border.\
(**A--C**) Representative images of synaptic tiling marker (*wyIs446*) overexpressing *mig-15* in DA9 from wild type (**A**), *plx-1(nc36)* (**B**) and *rap-2(gk11)* (**C**). Synaptic domains of DA8 and DA9 highlighted with green and magenta lines, respectively. Asterisks: DA9 cell body. Arrows: dorsal commissure of DA9. Scale bars: 20 μm. (**D**) Schematic illustration of synapse distribution in wild type (left), animals overexpressing *mig-15* in DA9 (middle) and synaptic tiling mutants overexpressing *mig-15* in DA9 (right). Arrows indicate the synaptic tiling border. Colored arrows represent expanded or shortened synaptic domain from DA8 (green) and DA9 (magenta). (**E**) Quantification of the DA8 asynaptic domain. (**F**) Quantification of the DA9 synaptic domain. Each dot represents measurements from a single animal. Blue bars indicate mean ± SEM. n.s.: not significant; \*\*\*p\<0.001. (**G**) A model of synaptic tiling. PLX-1/RAP-2 signaling controls synaptic tiling via MIG-15, while MIG-15 also plays crucial roles in inhibiting the number of synapses. Solid lines indicate putative direct regulations, dotted lines represent indirect or unknown mode of regulations.](elife-38801-fig8){#fig8}

Rap GTPase and TNIK are well-known actin cytoskeleton regulators ([@bib39], [@bib40]; [@bib74]). Previous studies demonstrated that presynaptic development requires ARP2/3-dependent branched F-actin ([@bib7], [@bib6]). Branched F-actin visualized by GFP::ut-CH (utrophin calponin homology domain) is enriched within the DA9 synaptic domain ([Figure 7E](#fig7){ref-type="fig"}) ([@bib7]; [@bib46]). We predicted that *mig-15* negatively regulates synapse formation by re-organizing branched F-actin at the anterior edge of the synaptic domain. Consistently, we observed longer synaptic F-actin distribution in *rap-2(gk11)* and *mig-15(rh148)* mutants ([Figure 7F, G and I](#fig7){ref-type="fig"}). While GFP::ut-CH was observed in the posterior asynaptic axonal region or in the dendrite of DA9, synapse formation is likely inhibited by Wnt and Netrin signaling as previously reported ([@bib36]; [@bib65]). Conversely, overexpression of *mig-15* in DA9 significantly decreased the length of synaptic F-actin ([Figure 7H and I](#fig7){ref-type="fig"}). Overexpression of *mig-15* also appeared to decrease the overall amount of synaptic F-actin ([Figure 7H](#fig7){ref-type="fig"}). This result suggests that *mig-15* inhibits synapse formation by negatively regulating the formation of synaptic F-actin.

*plx-1* and *rap-2* coordinate synaptic tiling border positioning and synapse number  {#s2-7}
-------------------------------------------------------------------------------------

*mig-15(OE)* reduced the number of synapses in DA9. As a result, the length of the DA9 synaptic domain was significantly reduced in *mig-15(OE)* animals than in wild type ([Figure 8A and E](#fig8){ref-type="fig"}). Yet, synaptic tiling is maintained without a significant gap between DA8 and DA9 synaptic domains in *mig-15(OE)* animals, suggesting that the position of synaptic tiling border shifted posteriorly in *mig-15(OE)* animals. Indeed, the length of the posterior asynaptic domain of DA8 was significantly shorter in *mig-15(OE)* animals, indicating that the DA8 synaptic domain expanded posteriorly ([Figure 8D](#fig8){ref-type="fig"}). The PLX-1::GFP patch at the anterior edge of the DA9 synaptic domain also shifted posteriorly in *mig-15(OE)* animals with reduced synapse number ([Figure 3D](#fig3){ref-type="fig"}). These results strongly suggest that the PLX-1/RAP-2 signaling pathway may specify the position of the synaptic tiling border according to the available number of synapses in each DA neuron ([Figure 8G](#fig8){ref-type="fig"}). We propose that synaptic tiling is a mechanism to maintain a uniform distribution of synapses from one class of motor neuron in the nerve cord. Consistently, we found that DA8 synaptic domain did not shift posteriorly when *mig-15* was overexpressed in DA9 of the synaptic tiling mutants, *plx-1* or *rap-2* ([Figure 8B--E](#fig8){ref-type="fig"}). This result suggests that DA8 no longer senses the reduction of DA9 synapse number in the synaptic tiling mutants. Synapse number was not different between *mig-15(OE)* and in *rap-2(gk11); mig-15(OE)* animals ([Figure 7---figure supplement 1](#fig7s1){ref-type="fig"}), suggesting that *mig-15* is not dependent on the Plexin/Rap2 signaling pathway to inhibit synapse number ([Figure 8G](#fig8){ref-type="fig"}).

In summary, we demonstrate that synaptic tiling maintains a uniform distribution of synapses from one class of motor neurons along the nerve cord. Further, our results indicate *plx-1* and *rap-2* play critical roles in this process by coordinating the position of the synaptic tiling border.

Discussion {#s3}
==========

While much is known about the morphogenic triggers for axon guidance and patterned synapse formation, the downstream sequelae of these intracellular effectors have remained unclear. We discovered the role of Rap2 GTPase and TNIK in synapse pattern formation in *C. elegans*. Since Sema/Plexin signaling processes to inhibit synapse formation are well conserved across species, we propose that Sema/Plexin in mammals also utilize Rap2 and TNIK to regulate synapse patterning.

Cell autonomous and non-autonomous functions of Sema/Plexin signaling components {#s3-1}
--------------------------------------------------------------------------------

Previously we showed that both *smp-1* and *plx-1* are necessary and sufficient in DA9, which suggests that *smp-1* and *plx-1* act cell-autonomously in DA9 and non-autonomously in DA8 to regulate synaptic tiling. We proposed that Sema/PLX-1 in DA9 send a retrograde signal to DA8 through an unidentified signaling molecule (X) to induce the synaptic tiling pattern in DA8 ([@bib46]). However, we found that both *rap-2* and *mig-15* act cell autonomously, since our DA9-specific rescue experiment only rescued the DA9 phenotype, but not the DA8 phenotype. This conclusion is further supported since the synaptic tiling defects of these mutants were fully rescued when both neurons express functional *rap-2* cDNA or *mig-15* genomic DNA. We propose that each neuron utilizes a different set of cell surface proteins but share common intracellular mechanisms to specify synapse patterning. Diverse signaling and cell adhesion molecules, such as atrial natriuretic peptide receptor (NPR) and GPCRs, regulate Rap activity ([@bib26]; [@bib3]; [@bib84]). Screening for these potential Rap regulators should identify novel molecules that interact with Sema/Plexin and act in DA9.

Cycling of Rap GTPase activity in synaptic tiling {#s3-2}
-------------------------------------------------

We showed that proper synapse patterning requires both GDP- and GTP-forms of RAP-2. Considering that PLX-1 regulates the spatial distribution of RAP-2 activity and *mig-15* acts genetically downstream of *plx-1* in synaptic tiling, RAP-2 may also locally regulate MIG-15 (TNIK). While we did not observe a specific subcellular localization of GFP-MIG-15 in DA9 (data not shown), PLX-1 and RAP-2 may instead regulate MIG-15 activity rather than its spatial localization. Further biochemical characterization of MIG-15 regulation by GTP-RAP-2 or GDP-RAP-2 will elucidate the exact functions of RAP-2 in synapse patterning.

Small GTPase activity is regulated by GAP and GEF (Guanine nucleotide exchange factor) proteins. Yet, we did not observe significant synaptic tiling defects in mutants of putative RAP-2 GEFs, which include *pxf-1(RAPGEF2/6)* and *epac-1(RAPGEF3/4/5)* (data not shown) ([@bib18]; [@bib62]). We speculate that multiple RapGEFs act redundantly to activate RAP-2 in synaptic tiling.

*mig-15(TNIK)* may integrate multiple inhibitory cues during synapse formation {#s3-3}
------------------------------------------------------------------------------

*mig-15* mutants show a greater degree of overlap between DA8 and DA9 synaptic domains than *plx-1* or *rap-2* mutants. This effect partially occurs from excess synaptogenesis in the posterior asynaptic domain of both DA8 and DA9 neurons. Previously, we demonstrated that Wnt morphogens and their receptors, Frizzled, instruct synaptic topographic patterning by locally inhibiting synapse formation. Indeed, synaptic tiling defects in *mig-15* mutants was somewhat similar to the combined effect of *plx-1* and *wnt* mutants ([@bib47]). TNIK can act as a positive regulator of the canonical Wnt signaling pathway in colorectal cancer cells ([@bib43]; [@bib72]). While we do not know whether the canonical Wnt signaling pathway contributes to local inhibition of synapse formation, we propose that TNIK integrates multiple signaling pathways for precise synapse pattern formation.

In addition to its role in synapse pattern formation, our data indicate that *mig-15* also plays a role as a negative regulator of synapse number. Since neither *plx-1* nor *rap-2* mutants showed a significant increase in synapse number in DA9, *mig-15* may inhibit synapse formation in a different signaling pathway ([Figure 8G](#fig8){ref-type="fig"}). As we observed a global reduction of synaptic actin staining in animals over-expressing *mig-15,* we propose that *mig-15* controls synapse number by regulating synaptic F-actin.

The exact mechanisms of synaptic actin regulation by TNIK remain undetermined. TNIK could activate the JNK kinase pathway ([@bib74]; [@bib19]). The MIG-15/JNK-1 signaling pathway inhibits axonal branch formation in s *C. elegans* ensory neurons ([@bib8]). In contrast to these well-established roles of MIG-15/TNIK as an activator of the JNK pathway, we did not observe any synaptic tiling defect nor change in synapse number in *jnk-1* mutant animals ([Figure 5---figure supplement 2](#fig5s2){ref-type="fig"} and data not shown). Our results suggest *mig-15* does not inhibit synapse formation through the JNK pathway.

Due to the pleiotropic phenotype of the *mig-15* mutants, our genetic and phenotypic analyses of *mig-15* did not exquisitely reveal the mechanistic relationship between PLX-1 and MIG-15 in synaptic tiling regulation. Further biochemical studies of MIG-15 regulation by Plexin/Rap2 in synaptic tiling will elucidate the molecular mechanisms that underlie the role of MIG-15/TNIK in synapse pattern formation.

Plexin signaling and diseases {#s3-4}
-----------------------------

Aberrant neuronal wiring underlies many neurological disorders. Not surprisingly, Semaphorin and Plexin genes are associated with various neurodevelopmental disorders and intellectual disabilities, including autism spectrum disorders (ASD) and schizophrenia ([@bib42]; [@bib23]). For example, PLXNB1, SEMA3A, SEMA4D and SEMA6C are significantly upregulated in the prefrontal cortices of schizophrenic patients ([@bib14]; [@bib25]). On the other hand, non-synonymous variations in the Sema3D gene had a significant protective effect against developing schizophrenia ([@bib22]). More recent work showed that loss of Sema5A/PlexA2 signaling induces excess excitatory synapse formation in granule cells, which caused ASD-like behavioural defects in mice ([@bib13]).

Similar to Sema/Plexin signaling, TNIK is also associated with various neurological disorders, including schizophrenia and intellectual disabilities ([@bib1]; [@bib66]). TNIK can also physically bind and act with DISC1 (Disrupted in Schizophrenia 1) to regulate synaptic composition ([@bib81]). So, we propose that the Sema/Plexin/Rap2/TNIK signaling pathway plays a critical role to precisely define synaptic connections and its disruption may induce serious neurological disorders.

Interestingly, SNPs in Plexin genes are also associated with extremely high IQ ([@bib73]). Recent work suggests that loss of PlexinA1 confers better motor control in rodents due to increased synaptic connectivity in the corticospinal cord ([@bib28]). Further studies on the Plexin/Rap2/TNIK signaling pathway in synapse map formation, as presented here, will likely reveal the genetic basis of these disorders and conditions.

Materials and methods {#s4}
=====================

  ----------------------------------------------------------------------------------------------------------------------
  Reagent type (species)\      Designation     Source or reference               Identifiers   Additional information
  or resource                                                                                  
  ---------------------------- --------------- --------------------------------- ------------- -------------------------
  Gene\                        rap-2           NA                                C25D7.7       
  (*C. elegans*)                                                                               

  Gene\                        plx-1           NA                                Y55F3AL.1     
  (*C. elegans*)                                                                               

  Gene\                        mig-15          NA                                ZC504.4       
  (*C. elegans*)                                                                               

  Strain, strain background\   rap-2(gk11)     *C. elegans* stock center (CGC)   VC14          
  (*C. elegans*)                                                                               

  Strain, strain background\   mig-15(rh148)   *C. elegans* stock center (CGC)   NJ490         
  (*C. elegans*)                                                                               

  Strain, strain background\   plx-1(nc36)     *C. elegans* stock center (CGC)   ST36          
  (*C. elegans*)                                                                               

  Strain, strain background\   rap-2(miz18)    This study                        UJ401         G12V mutant
  (*C. elegans*)                                                                               

  Strain, strain background\   rap-2(miz19)    This study                        UJ402         S17A mutant
  (*C. elegans*)                                                                               

  Strain, strain background\   wyIs446         This study                        TV14517       synaptic tiling marker
  (*C. elegans*)                                                                               

  Strain, strain background\   mizIs19         This study                        UJ397         Rap2 FRET sensor strain
  (*C. elegans*)                                                                               
  ----------------------------------------------------------------------------------------------------------------------

Strains {#s4-1}
-------

All *C. elegans* strains were derived from Bristol N2 and raised on OP50 *Escherichia coli*-seeded nematode growth medium (NGM) plates at 20C and maintained as described previously ([@bib4]). The following mutants were used in this study: *unc-104(e1265)II, plx-1(nc36)IV, rap-1(pk2082)IV, rap-3(gk3975)IV, jnk-1(gk7)IV rap-2(gk11)V, rap-2(miz16)V, rap-2(miz17)V, rap-2(miz18)V, rap-2(miz19)V. rap-2(miz20)V, mig-15(rh148)X, mig-15(rh80)X, mig-15(rh326)X.*

CRISPR/Cas9 genome editing  {#s4-2}
---------------------------

*rap-2(miz16)V, rap-2(miz17)V, rap-2(miz18)V, rap-2(miz19)V. rap-2(miz20)V* were generated using Co-CRISPR method ([@bib35]). *unc-22* or *dpy-10* co-CRISPR markers were used for selecting candidate animals ([@bib35]; [@bib2]). Vectors for sgRNA and Cas9 were obtained from Addgene (Plasmid ID: 46169 and 46168, respectively) ([@bib17]). The *rap-2* guide RNA sequence (5' -- gTAGTGGAGGTGTCGGAAAAT-3') was designed using MIT CRISPR design tool (crispr.mit.edu:8079) and inserted into sgRNA vector using Q5 Site-Directed Mutagenesis kit (NEB). Repair templates with either G12V (*miz17* and *miz18*) and S17A (*miz19* and *miz20*) mutation were generated by PCR with primer sets carrying corresponding mutations (see supplemental Experimental Procesures). Synonymous mutations were also introduced in the sgRNA recognition sequence to avoid Cas9 recruitment to the edited genome. PCR products were cloned into *Eco*RI site of the pBluescript SK(+) vector. Synthesized double-stranded DNA (GeneArt, Thermo Fisher) was used as a repair template for generating *rap-2(miz16)* mutant.

Plasmid constructions {#s4-3}
---------------------

*C. elegans* expression clones were made in a derivative of pPD49.26 (A. Fire), the pSM vector (kind gift from S. McCarroll and C. I. Bargmann). Primer sets used in this study are listed in the Supplemental Experimental Procedures. The following constructs were used and transgenes were generated using standard microinjection method ([@bib45]): *wyIs446 (Punc-4::2xGFP-rab-3; Pmig-13::mCherry-rab-3; Podr-1::RFP), wyIs85 (Pitr-1::GFP-rab-3; Podr-1::RFP), wyIs442 (Pflp-13::2xGFP-rab-3; Pplx-2::mCherry-rab-3; Podr-1::RFP), wyIs320 (Pitr-1::plx-1::GFP; Pmig-13::mCherry;;rab-3; Podr-1::GFP), wyIs329 (Pmig-13::GFP-ut-CH; Pmig-13::mCherry::rab-3; Podr-1::GFP), wyIs524 (Punc-4::2xGFP-rab-3; Pmig-13::mCherry-rab-3; Podr-1::RFP), wyIs685 (Pmig-13::mCherry::rab-3; Pmig-13::GFPnovo2::cla-1; Podr-1::GFP) mizIs1 (Pitr-1::GFPnovo2-CAAX; Pvha-6::zif-1; Pitr-1::mCherry::rab-3; Podr-1::GFP), mizIs19 (Pmig-13::eGFP::hRap2a; Pmig-13::mRFP-RalGDS(RBD)-mRFP; Podr-1::GFP), mizIs33 (Prab-3::mig-15; Podr-1::GFP), jsIs682 (Prab-3::GFP::rab-3; lin-15(+)), wyEx5445 (Prap-1::GFP; Punc-4::myr-mCherry; Podr-1::RFP), wyEx5464 (Prap-2::GFP; Punc-4::myr-mCherry; Podr-1::RFP), mizEx194 (Prap-3::GFP; Pmig-13::myr-mCherry; Podr-1::RFP), mizEx165 (Phlh-1::rap-2; Podr-1::GFP), mizEx164 (Punc-129::rap-2; Podr-1::GFP), mizEx174 (Punc-4c::rap-2; Podr-1::GFP), mizEx157 (Pmig-13::rap-2; Podr-1::GFP), mizEx156 (Punc-4c::hRap2a; Podr-1::GFP), mizEx177 (Punc-4c::rap-1; Podr-1::GFP), mizEx151 (Pmig-13::mig-15; Podr-1::GFP), mizEx147 (Punc-4c::mig-15; Podr-1::GFP), mizEx153 (ΔpSMmig-15; Podr-1::GFP), mizEx178 (Punc-4c::mig-15(K50A); Podr-1::GFP), mizEx173 (Punc-4::rap-2(G12V); Podr-1::GFP), mizEx179 (Pflp-13::mig-15; Podr-1::GFP), mizEx170 (Pmig-13::mig-15; Podr-1::GFP), mizEx197 (Pmig-13::mig-15; Podr-1::GFP), mizEx210 (Pmig-13::mig-15; Podr-1::RFP), mizEx257 (Prab-3::GFP; Prab-3::mCherry::rab-3, Podr-1::mScarlet::CAAX), mizEx272 (Podr-1::GFP; Pmig-13::unc-10::TdTomato); mizEx309 (Pmig-13::plx-1(RA); Podr-1::RFP), mizEx312 (Pmig-13::plx-1(Δsema); Podr-1::RFP); mizEx314 (Pmig-13::plx-1; Podr-1::RFP).*

Cloning of *rap-1, rap-2* and *mig-15* {#s4-4}
--------------------------------------

cDNAs of *rap-1* and *rap-2* were obtained from cDNA library prepared from N2 RNA. Trizol (Invitrogen) was used to purify total RNA from N2, and the SuperScript III First-Strand Synthesis System for RT-PCR (Invitrogen) was used for the reverse-transcription. *mig-15* genomic DNA was amplified from the N2 genomic DNA purified using GeneJET *Genomic* DNA Purification Kit (Thermo Scientific). Phusion (NEB) or Q5 (NEB) DNA polymerases were used for all PCR reactions for amplifying cDNA and genomic DNA fragments. Amplified fragments were cloned into the *Asc*I and *Kpn*I sites of pSM vector using SLiCE method ([@bib48]), Gibson assembly ([@bib24]) or T4 ligase (NEB). List of primers used in this study is available in the Supplemental Experimental Procedures.

Confocal microscopy {#s4-5}
-------------------

Images of fluorescently tagged fusion proteins were captured in live *C. elegans* using a Zeiss LSM800 confocal microscope (Carl Zeiss, Germany). Worms were immobilized on 2% agarose pad using a mixture of 7.5 mM levamisole (Sigma-Aldrich) and 0.225M BDM (2,3-butanedione monoxime) (Sigma-Aldrich). Images were analyzed with Zen software (Carl Zeiss) or Image J (NIH, USA). Definition of each parameter is as follows ([@bib46]): DA8/9 overlap: a distance between the most anterior DA9 synapse and the most posterior DA8 synapse, DA8 asynaptic domain: a distance from commissure to the most posterior DA8 synapse, DA9 synaptic domain: a distance between the most anterior and posterior DA9 synapses. Middle L4 (judged by the stereotyped shape of developing vulva) animals were used for quantification. Averages were taken from at least 20 samples. For GFP::Utrophin-CH, we measured the length from the posterior end of dorsal axon to the anterior end of GFP::Utrophin-CH domain. For each marker strain, the same imaging setting (laser power, gain pinhole) and image processing were used for comparing different genotypes.

Two-photon FLIM-FRET experiment {#s4-6}
-------------------------------

Expression vector for cultured cells (pCI-eGFP-hRap2a, pCI-eGFP-RAP-1, pCI-eGFP-RAP-2, pCI-eGFP-RAP-2(G12V), pCI-eGFP-RAP-2(S17A)) were generated by replacing Ras in pCI-eGFP-Ras (Yasuda et al., 2006) with hRap2a and *rap-2* cDNAs with *Xho*I and *Bam*HI. pCI-mRFP-RalGDS-mRFP plasmid is a kind gift from Dr. Yasuda. Rap2 and FRET sensor plasmids were mixed in 1:2 ratio and transfected into HeLa cells using Lipofectamine 3000 (ThermoFisher). FLIM was conducted 24 hr after transfection. For expression of FRET sensor in the DA9 neuron, each fusion protein constructs were cloned into *Asc*I and *Kpn*I sites of the pSM vector containing *mig-13* promoter using SLiCE method.

A custom-made two-photon fluorescence lifetime imaging microscope was used as described elsewhere (Murakoshi et al., 2011). Briefly, EGFP-Rap2a was excited with a Ti-sapphire laser (Mai Tai; Spectra-Physics) tuned to 920 nm. The X and Y scanning galvano mirrors (6210 hr; Cambridge Technology) were controlled with ScanImage software ([@bib64]). EGFP photon signals were collected an objective lens (60×, 1.0 NA; Olympus) and a photomultiplier tube (H7422-40p; Hamamatsu) placed after a dichroic mirror (FF553-SDi01; Semrock) and emission filter (FF01-510/84; Semrock). A fluorescence lifetime curve was recorded by a time-correlated single-photon-counting board (SPC-150; Becker and Hickl) controlled with the software described previously (Yasuda et al., 2006). For construction of a fluorescence lifetime image, the mean fluorescence lifetime values (τ~m~) in each pixel were translated into a color-coded image. We quantified free EGFP-Rap2a and EGFP-Rap2a undergoing FRET (binding fraction) as described elsewhere (Yasuda et al., 2006). Briefly, we calculated the proportion of EGFP undergoing FRET in individual ROIs using the following formula:$$P_{FRET} = \frac{\tau_{free}(\tau_{free} - \tau_{m})}{(\tau_{free} - \tau_{FRET})(\tau_{free} + \tau_{FRET} - \tau_{m})}P_{FRET} = \frac{\tau_{free}(\tau_{free} - \tau_{m})}{(\tau_{free} - \tau_{FRET})(\tau_{free} + \tau_{FRET} - \tau_{m})}$$where τ~free~ and τ~FRET~ are the fluorescence lifetime of free EGFP and EGFP undergoing FRET, respectively.

Statistics {#s4-7}
----------

Prism (GraphPad) software was used for statistical analysis. One-way ANOVA was done and corrected for multiple comparisons with posthoc Tukey\'s multiple comparisons tests done between all genotypes. Student's t-test was used for pairwise comparison. Sample numbers were pre-determined before conducting statistical analyses.

Supplemental experimental procedures {#s4-8}
------------------------------------

The method for qRT-PCR and sequences of primers and repair templates used in this study are available in [Supplementary file 1](#supp1){ref-type="supplementary-material"}.
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Decision letter

Sengupta

Piali

Reviewing Editor
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United States

In the interests of transparency, eLife includes the editorial decision letter and accompanying author responses. A lightly edited version of the letter sent to the authors after peer review is shown, indicating the most substantive concerns; minor comments are not usually included.

\[Editors' note: a previous version of this study was rejected after peer review, but the authors submitted for reconsideration. The first decision letter after peer review is shown below.\]

Thank you for submitting your work entitled \"Rap2 and TNIK control Plexin-dependent synaptic tiling in *C. elegans*\" for consideration by *eLife*. Your article has been reviewed by a Senior Editor, a Reviewing Editor, and three reviewers. The reviewers have opted to remain anonymous.

Our decision has been reached after consultation among the reviewers. Based on these discussions and the individual reviews below, we regret to inform you that your work will not be considered further for publication in *eLife*.

All reviewers appreciate the focus on identifying new genes and pathways regulating synaptic tiling. However, to some extent, many of the molecular players implicated in this manuscript have previously been identified in the Sema/Plexin pathway in other contexts (Plexin implicated by this lab in synaptic tiling, Rap is a known target of Plexin signaling, MIG-15/TNIK is a known regulator of Rap). A strength of your manuscript is the description of the roles of all these components in a pathway that regulates synaptic tiling. However, given this, as the reviewers note, there are several gaps/weaknesses in the current analyses tying these components together. The reviewers suggest several experiments to strengthen the work.

Reviewer \#1:

This is an interesting study that is the next step in defining the signaling pathway(s) downstream of PLX-1 signaling in regulating tiling of DA8 and DA9 motor neuron synapses. The data supporting a cell-autonomous role for *rap-2* downstream of *plx-1* are convincing, however they are also expected (that at least one *C. elegans* Rap homolog would be downstream) based on other studies of Plexin signaling.

While *mig-15* is clearly doing something interesting in terms of inhibiting synapse formation throughout the worm, the data implicating MIG-15 downstream of PLX-1 RAP-2 signaling is less convincing. The authors\' results with respect to MIG-15 feel like the beginning of a new story, and not just a new molecule downstream of Plexins.

Reviewer \#2:

In this manuscript, the authors use *C. elegans* DA9 and DA8 neurons as the model to investigate synaptic tilling. The authors describe a potential important role of Rap2 and TNIK in regulating the synaptic tilling of DA neurons. The authors present genetic evidence to support the function of Rap2 and TNIK in this process, however the evidence to link Semaphorin receptors with Rap2 or TNIK was relatively weak.

1\) The authors show that both gain-of function and loss-of-function of *rap-2* have similar phenotypes. They use *rap-2* (G12V) as a gain-of-function mutation for RAP-2, is this mutation really cause gain-of-function in *C. elegans* neurons? The authors need either cite published results or test it by themselves.

2\) The authors use the co-localzation of mCherry::RAB-3 with CLA-1 as evidence to show those synapses are \"functional synapses\". To really reach the conclusion that those synapses are functional synapses, one needs to show either those synapses have similar structures as \"normal\" synapses, or to show those synapses have similar ability to release neuronal transmitters. I would suggest the authors either use other term (rather than functional synapse) to describe the phenotype or carry out EM or electrophysiology studies to prove that those synapses are functional synapses. It will also be helpful if the authors can test other synaptic markers such as SNB-1, SID-1, SYD-2, to confirm the results.

3\) The link between PLX-1 with Rap2 activation was wake. The authors show the activation of RAP-2 has correlation with the localization of PLX-1, but this doesn\'t mean the activation of RAP-2 is directly regulated by the PLX-1 or depend the activation of PLX-1. Since this is one of the major conclusions of the paper, some direct evidence is needed to prove the activation of RAP2 is indeed locally and directly regulated by PLX-1 and the PLX-1 ligand. Otherwise, the authors need to revise their conclusion.

4\) As shown in Figure 7, *mig-15*(OE) seems to affect the tilling border DA8/DA9/. Does *mig-15*(OE) also affect the localization of PLX-1 and the local activation of Rap2?

Reviewer \#3:

Chen et al., identify the small GTPase *rap-2* and its effector *mig-15*/TNIK as novel regulators of synaptic tiling in DA8/DA9 motor neurons in *C. elegans*, and further show that MIG-15 inhibits synapse formation in multiple neuron types. Mizumoto et al. (2013) previously showed that Semaphorin/Plexin signaling regulates branched actin via the Plexin GAP domain to control synaptic tiling between DA8 and DA9. Semaphorin/Plexin signaling is known to inhibit synapse formation (Matthes, 1995, Tran, 2009, Duan, 2014, O\'Connor, 2009), however the intracellular signaling mechanisms that connect Plexin to synapse development are not known. Based on published data, cited by the authors, Plexins are known to inhibit the Rap family of small GTPases to regulate actin remodeling (Wang, 2012, Wang, 2013), and TNIK family kinases are known downstream effectors of Rap-GTP (Hussain, 2010, Kawabe, 2010, Nonaka, 2008). Thus, the authors test if *C. elegans* Rap family members and *mig-15*/TNIK regulate synaptic tiling downstream of PLX-1. Chen et al. found that *rap-2* and *mig-15* mutants have strong defects in synaptic tiling. The authors use FLIM-based FRET to show that RAP2A is inhibited locally at the synaptic tiling border between DA8 and DA9, and this local effect is abrogated in *plx-1* mutants. They show that *rap-2* functions in DA9 neurons to regulate synaptic tiling and use genetic double mutants to show that *plx-1* and *rap-2* act in the same pathway. Chen et al., identify the Rap-GTP effector kinase, *mig-15*/TNIK as a novel regulator of synaptic tiling and, interestingly, as a general inhibitor of synapse formation throughout the nervous system.

1\) The images showing PLX-1::GFP localization to the tiling border are not clear. Mizumoto et al., previously showed that PLX-1::GFP is highly expressed and diffuse in the ventral dendrite and asynaptic regions of the axon including in the axon commissure and also anterior to the synaptic tiling border, with some dimmer puncta within the synaptic region (Neuron 2013). In this manuscript (Figure 3A-B), PLX-1::GFP is much dimmer and punctate at the tiling border. Better images and quantification of PLX-1::GFP distribution, as previously performed, would improve this data.

2\) In Figure 3F-G, the authors show that local inhibition of Rap2A at the tiling border does not happen in the absence of *plx-1* and conclude that the data \"strongly suggest that Plexin localized at the anterior edge of the DA9 synaptic domain locally inactivates Rap2A GTPase to delineate the synaptic tiling border in DA9.\" Since *plx-1* mutants are missing PLX-1 in the whole animal including throughout DA9, a better experiment might be to rescue the mutant with PLX-1(ΔSema)::GFP, which the authors previously showed was mislocalized throughout DA9, and show that mislocalized, inactive PLX-1 does not rescue the local inactivation of Rap2A. And importantly, does GAP-deficient PLX-1(RA)::GFP, which the authors previously showed was properly localized to the tiling border, show no change in local Rap2A activity?

3\) Can the authors show that there are no subtle defects in DA8/DA9 axon contact in *mig-15* mutants that could explain the stronger synaptic tiling defects? The authors show that *mig-15* mutants have strong defects in axon outgrowth and branching in about 50% of the animals (Figure 5---figure supplement 1). In addition, *mig-15* mutants have a more dramatic DA8/DA9 overlap phenotype (50-55um overlap in Figure 4) compared to *plx-1* or *rap-2* mutants (which have \~30um overlap in Figure 1). The authors previously showed (Mizumoto et al., 2013) that in axon guidance mutants unc-34 and unc-129, DA9 is misguided and does not make axon contacts in the dorsal cord leading to strong DA8/DA9 synaptic tiling overlap defects (up to 50um). Thus, it is not clear if the DA8/DA9 overlap defects observed in *mig-15* mutants are primarily due to axon guidance defects (i.e. more subtle defects where DA8 and DA9 do not contact each other) or to a more direct role for *mig-15* in synaptic tiling.

4\) It is not clear whether *mig-15* acts upstream, downstream or in parallel to plx-1 and *rap-2* to regulate synaptic patterning. If MIG-15 acts downstream of PLX-1, and Rap-2-GTP binds and activates TNIK/MIG-15 to inhibit synapse formation, then MIG-15(OE) should inhibit synapse formation independent of *plx-1* and *rap-2*. Instead, Figure 7E appears to show that the effects of MIG-15(OE) on DA9 synapses are suppressed by *plx-1* or *rap-2*. The interpretation of these results should be clarified. Also, it would be helpful if *plx-1* and *rap-2* single mutants are shown for comparison in Figure 7E to determine whether MIG-15 functions upstream of *plx-1* and *rap-2* or in parallel.

5\) Have the authors tested if there are any functional/ behavioral consequences to defects in synaptic tiling between DA8 and DA9?

\[Editors' note: what now follows is the decision letter after the authors submitted for further consideration.\]

Thank you for submitting your article \"Rap2 and TNIK control Plexin-dependent synaptic tiling in *C. elegans*\" for consideration by *eLife*. Your article has been reviewed by K VijayRaghavan as the Senior Editor, a Reviewing Editor, and three reviewers. The reviewers have opted to remain anonymous.

The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.

While all reviewers appreciate the additional data and analyses presented in this manuscript, and the extent to which previous comments have been addressed, the major remaining concern is about the placement of MIG-15 in the PLX-1 pathway. The data supporting the notion that MIG-15 is downstream of PLX-1 are weak. While this issue is addressed in part in Figure 8, the manuscript should be revised to address this concern. Specifically, the manuscript should overtly state the limitations of the genetic and phenotypic analyses and only speculate about the mechanistic relationship between MIG-15 and PLX-1.

10.7554/eLife.38801.024

Author response

\[Editors' note: the author responses to the first round of peer review follow.\]

> Reviewer \#1:
>
> This is an interesting study that is the next step in defining the signaling pathway(s) downstream of PLX-1 signaling in regulating tiling of DA8 and DA9 motor neuron synapses. The data supporting a cell-autonomous role for rap-2 downstream of plx-1 are convincing, however they are also expected (that at least one C. elegans Rap homolog would be downstream) based on other studies of Plexin signaling.

We appreciate the reviewer's enthusiasm in our work. While it is indeed already shown that Plexin functions as a RapGAP, our work is the first to show the role of Plexin/Rap signaling in synapse pattern formation in vivo. More importantly, using FLIM, we show for the first time that Plexin controls the spatial activity of Rap2 small GTPase within the specific axonal segment. With our additional data to support this observation as described below, we believe that this work provides a significant advance in our knowledge of the Plexin/Rap2 signaling pathway in synapse pattern formation.

> While mig-15 is clearly doing something interesting in terms of inhibiting synapse formation throughout the worm, the data implicating MIG-15 downstream of PLX-1 RAP-2 signaling is less convincing. The authors\' results with respect to MIG-15 feel like the beginning of a new story, and not just a new molecule downstream of Plexins.

We absolutely agree with the reviewer's comment. This work is a beginning of our next exciting challenge in understanding the roles of TNIK/MIG-15 in inhibiting presynaptic development. While the larger synaptic tiling defects we observed in *mig-15* mutants clearly suggests that *mig-15* functions in multiple pathways as we discussed in the Discussion section, we still believe that *mig-15* functions downstream of *plx-1* in synaptic tiling. The critical observation we added this time was PLX-1::GFP localization was not affected in the *mig-15(rh148)* mutant background, while ectopic synapses are formed beyond the PLX-1::GFP patch at the putative synaptic tiling border. This data strongly suggests that *mig-15* controls synapse patterning downstream of PLX-1. We therefore believe that it is appropriate to include *mig-15* as a Plexin/Rap2 signaling component in this manuscript.

> Reviewer \#2:
>
> In this manuscript, the authors use C. elegans DA9 and DA8 neurons as the model to investigate synaptic tilling. The authors describe a potential important role of Rap2 and TNIK in regulating the synaptic tilling of DA neurons. The authors present genetic evidence to support the function of Rap2 and TNIK in this process, however the evidence to link Semaphorin receptors with Rap2 or TNIK was relatively weak.
>
> 1\) The authors show that both gain-of function and loss-of-function of rap-2 have similar phenotypes. They use rap-2(G12V) as a gain-of-function mutation for RAP-2, is this mutation really cause gain-of-function in C. elegans neurons? The authors need either cite published results or test it by themselves.

As we showed in Figure 1, expression of *rap-2(G12V)* in wild-type background caused synaptic tiling defects, suggesting that *rap-2(G12V)* is a gain-of-function mutant. We observed no synaptic tiling defects when we injected wild-type *rap-2* under the same *unc-4* promoter in wild-type. This confirms that the synaptic tiling defect observed in animals expressing *rap-2(G12V)* is not due to the over-expression but rather the G12V mutation itself. This data is included in the revised Figure 1. We also rephrased 'over-expression' to 'expression' in the following sentence:

"Expression of a constitutively GTP-bound form of *rap-2* (G12V) under the A-type neuron specific promoter, *Punc-4*, elicited a similar synaptic tiling defect as *plx-1* mutants (Figures 1C and 1G). Expression of wild type *rap-2* under the unc-4 promoter did not affect the synaptic tiling pattern, suggesting that G12V mutation but not over-expression of *rap-2* caused the synaptic tiling defect (Figure 1G).*"*

hRap2A 1 MREYKVVVLGS**G**GVGKSALTVQFVTGTFIEKYDPTIEDFYRKEIEVDSSPSVLEILDTAG 60

MRE+KVVVLGSGGVGKSALTVQFV+ TFIEKYDPTIEDFYRKEIEVD PSVLEILDTAG

RAP-2 1 MREFKVVVLGS**G**GVGKSALTVQFVSSTFIEKYDPTIEDFYRKEIEVDGQPSVLEILDTAG 60

In addition, considering the high sequence identity between *C. elegans* RAP-2 and human Rap2A (please see above sequence comparison), and the fact that G12V mutation is widely used as a constitutively active mutant for many small GTPases including Ras, Rac, Cdc42, Rap (including RAP-1 in *C. elegans:* MBC 2005 16(1): 106--116), we believe that *C. elegans* RAP-2 (G12V) is also a gain-of-function mutant.

We added the following sentence to explain G12V mutation generally used in Rap GTPase field.

The G12V mutant is widely used as a constitutively GTP-form of small GTPases including mammalian Rap2A and *C. elegans* RAP-1 (Kawabe et al., 2010; Pellis van Berkal et al., 2005).

We also conducted GST-RalGDS(RBD) pull-down assay in 293T cell line, which is a well-established assay to detect GTP-form of Rap small GTPase (McLeod et al., JBC 1998; Lin et al., Oncogene 2010) and found that *C. elegans* RAP-2(G12V) was coimmunoprecipitated with RalGDS (See [Author response image 1](#respfig1){ref-type="fig"}). We were a little bit hesitant to put this figure in the manuscript since we did not detect *C. elegans* RAP-2 in the lysate due to low expression in 3 replicates (right gel), which hindered us from conducting quantitative analysis. Nevertheless, this data is also consistent with the idea that *C. elegans* RAP-2(G12V) is a constitutively active form.

The FLIM-FRET experiment we showed in response to reviewer1's comment 2 also suggests that RAP-2(G12V) is a constitutively GTP-bound form.

![](elife-38801-resp-fig1){#respfig1}

> 2\) The authors use the co-localzation of mCherry::RAB-3 with CLA-1 as evidence to show those synapses are \"functional synapses\". To really reach the conclusion that those synapses are functional synapses, one needs to show either those synapses have similar structures as \"normal\" synapses, or to show those synapses have similar ability to release neuronal transmitters. I would suggest the authors either use other term (rather than functional synapse) to describe the phenotype or carry out EM or electrophysiology studies to prove that those synapses are functional synapses. It will also be helpful if the authors can test other synaptic markers such as SNB-1, SID-1, SYD-2, to confirm the results.

We now examined another active zone markers, UNC-10::TdTomato, which colocalized with RAB-3 synaptic vesicle markers in the *plx-1, rap-2* and *mig-15* mutants. The representative images are in Figure S3. We also re-phrased 'functional synapses' to 'bona fide synapses'.

> 3\) The link between PLX-1 with Rap2 activation was wake. The authors show the activation of RAP-2 has correlation with the localization of PLX-1, but this doesn\'t mean the activation of RAP-2 is directly regulated by the PLX-1 or depend the activation of PLX-1. Since this is one of the major conclusions of the paper, some direct evidence is needed to prove the activation of RAP2 is indeed locally and directly regulated by PLX-1 and the PLX-1 ligand. Otherwise, the authors need to revise their conclusion.

We appreciate the reviewer's comment. This is also raised by the reviewer 3. As reviewer 3 suggested, we conducted additional FLIM experiments using two mutant PLX-1 rescuing constructs; one cannot be activated by Semaphorin; the other has no GAP activity but can localize normally (please see our response to reviewer 3, comment 2 for details). Neither of them rescued the local Rap2 inactivation pattern. These data strongly support our model that PLX-1 controls local RAP-2 activity.

Regarding whether PLX-1 directly regulates Rap2, we do not have clear evidence for this and therefore did not mention that it was direct. However, we think it is highly likely since structural and biochemical experiments using mammalian Plexin nicely showed that Plexin is a RapGAP. To clarify our conclusion, we added the following sentence.

"While we do not fully exclude the possibility that PLX-1 indirectly regulated local Rap2 activity, together with the biochemical evidence that mammalian Plexin acts as RapGAP (Wang et al., 2012; 2013), these data strongly suggests that Plexin localized at the anterior edge of the DA9 synaptic domain locally inactivates Rap2 GTPase to delineate the synaptic tiling border in DA9."

> 4\) As shown in Figure 7, mig-15(OE) seems to affect the tilling border DA8/DA9/. Does mig-15(OE) also affect the localization of PLX-1 and the local activation of Rap2?

We indeed observed the posterior shift of PLX-1::GFP in animals expressing *mig-15.* A representative image is now included in Figure 3.Due to the variability of the phenotype caused by *mig-15* overexpression from an extrachromosomal array, we were not able to quantify the shift of PLX-1::GFP. For the same variability issue, we were not able to conduct FLIM experiment.

> Reviewer \#3:
>
> \[...\] 1) The images showing PLX-1::GFP localization to the tiling border are not clear. Mizumoto et al., previously showed that PLX-1::GFP is highly expressed and diffuse in the ventral dendrite and asynaptic regions of the axon including in the axon commissure and also anterior to the synaptic tiling border, with some dimmer puncta within the synaptic region (Neuron 2013). In this manuscript (Figure 3A-B), PLX-1::GFP is much dimmer and punctate at the tiling border. Better images and quantification of PLX-1::GFP distribution, as previously performed, would improve this data.

We appreciate the reviewer's suggestion. We re-set the imaging condition for PLX-1::GFP so that the PLX-1::GFP patch is now more obvious than the original ones. We also added the quantification of the signals in Figure 3.

> 2\) In Figure 3F-G, the authors show that local inhibition of Rap2A at the tiling border does not happen in the absence of plx-1 and conclude that the data \"strongly suggest that Plexin localized at the anterior edge of the DA9 synaptic domain locally inactivates Rap2A GTPase to delineate the synaptic tiling border in DA9.\" Since plx-1 mutants are missing PLX-1 in the whole animal including throughout DA9, a better experiment might be to rescue the mutant with PLX-1(ΔSema)::GFP, which the authors previously showed was mislocalized throughout DA9, and show that mislocalized, inactive PLX-1 does not rescue the local inactivation of Rap2A. And importantly, does GAP-deficient PLX-1(RA)::GFP, which the authors previously showed was properly localized to the tiling border, show no change in local Rap2A activity?

We again appreciate the reviewer's insightful suggestion. We conducted the suggested experiments and indeed observed no rescue in Rap2 activity pattern when PLX-1(ΔSema) or PLX-1(RA) was expressed in DA9. On the other hand, expression of wildtype PLX-1 nicely recreated the region with low Rap2 activity in the *plx-1* mutant background. This observation strengthens our conclusion that PLX-1 locally inhibits Rap2 activity at the synaptic tiling border.

We believe this experiment also answered the question 3 from reviewer 2. The new data is now added to Figure 4.

> 3\) Can the authors show that there are no subtle defects in DA8/DA9 axon contact in mig-15 mutants that could explain the stronger synaptic tiling defects? The authors show that mig-15 mutants have strong defects in axon outgrowth and branching in about 50% of the animals (Supplemental Figure 4). In addition, mig-15 mutants have a more dramatic DA8/DA9 overlap phenotype (50-55um overlap in Figure 4) compared to plx-1 or rap-2 mutants (which have \~30um overlap in Figure 1). The authors previously showed (Mizumoto et al., 2013) that in axon guidance mutants unc-34 and unc-129, DA9 is misguided and does not make axon contacts in the dorsal cord leading to strong DA8/DA9 synaptic tiling overlap defects (up to 50um). Thus, it is not clear if the DA8/DA9 overlap defects observed in mig-15 mutants are primarily due to axon guidance defects (i.e. more subtle defects where DA8 and DA9 do not contact each other) or to a more direct role for mig-15 in synaptic tiling.

In our previous paper, we showed that the PLX-1::GFP localization is dependent on the axon-axon interaction. In the axon guidance mutants in which axon-axon interaction between DA8 and DA9 is disrupted, PLX-1::GFP was distributed evenly throughout the axon. In *mig-15* mutants, PLX-1::GFP localization was largely unaffected, suggesting that the synaptic tiling defect in *mig-15* is not due to the loss of axon-axon interaction between DA8 and DA9. Now this data is included in Figure 3. We added the following sentence in the revised manuscript.

"The PLX-1::GFP patch at the putative synaptic tiling border was unaffected in *mig-15* mutants, even though the position of the PLX-1::GFP patch has shifted slightly posteriorly compared with wild-type animals (Figure 3C), suggesting that *mig-15* acts downstream of PLX-1 in regulating synaptic tiling."

In addition, we did not observe severe synaptic tiling defect in *cdh-4(rh310)*, which showed axon defasciculation phenotype in the dorsal nerve cord neurons (Schmitz et al., 2008). The overlap between DA8 and DA9 synaptic domains was 4.6 µm (n=21, SEM ± 1.02). This observation also supports the idea that the large overlap between DA8 and DA9 synaptic domains in *mig-15* mutants is not due to the loss of axon-axon interaction. We included the following sentence:

"In addition, we did not observe significant synaptic tiling defects in *cdh-4(rh310)* mutants (4.6 ± 1.02 µm, n=21), which exhibits axon defasciculation phenotype in the dorsal nerve cord neurons (Schmitz et al., 2008). These data suggest that the synaptic tiling defect in the *mig-15* mutants is not a secondary effect of axon outgrowth and guidance."

> 4\) It is not clear whether mig-15 acts upstream, downstream or in parallel to plx-1 and rap-2 to regulate synaptic patterning. If MIG-15 acts downstream of PLX-1, and Rap-2-GTP binds and activates TNIK/MIG-15 to inhibit synapse formation, then MIG-15(OE) should inhibit synapse formation independent of plx-1 and rap-2. Instead, Figure 7E appears to show that the effects of MIG-15(OE) on DA9 synapses are suppressed by plx-1 or rap-2. The interpretation of these results should be clarified. Also, it would be helpful if plx-1 and rap-2 single mutants are shown for comparison in Figure 7E to determine whether MIG-15 functions upstream of plx-1 and rap-2 or in parallel.

We believe that *mig-15* has two roles. First, *mig-15* acts downstream of *plx-1* and *rap-2* in synapse patterning (or synaptic tiling). We propose this based on the synaptic tiling defect (but normal PLX-1 localization) in *mig-15* mutants. Second, *mig-15* functions as a key negative regulator of synapse number. Since we did not observe a significant increase in synapse numbers in *plx-1* or *rap-2* mutants, the role of *mig-15* in controlling synapse number is independent of Plexin signaling pathway. Indeed, the reduction of synapse number in *mig-15-*overexpressing animals is not suppressed in *plx-1* or *rap-2* mutants. We added the following sentence in the revised manuscript to clarify the relationship between Plex/Rap pathway and *mig-15.*

"Synapse number was not different in mig-15(OE) and *rap-2*(gk11); mig-15(OE) animals, suggesting that the role of mig-15 in inhibiting synapse number is not dependent on Plexin/Rap2 signaling pathway (Figure S6)."

> 5\) Have the authors tested if there are any functional/ behavioral consequences to defects in synaptic tiling between DA8 and DA9?

All synaptic tiling mutants we have isolated so far, except for *mig-15* mutantswhich are sick and hence do not move well, exhibit superficially normal locomotion. This is probably due to the functional redundancy in the motor circuit, in which subtle synaptic pattern defect could be compensated by other mechanisms. Most of the *C. elegans* mutants with synapse patterning defects indeed show minimal locomotion defects, and hence have been missed from the traditional locomotion-based genetic screenings.

\[Editors\' note: the author responses to the re-review follow.\]

> The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.
>
> While all reviewers appreciate the additional data and analyses presented in this manuscript, and the extent to which previous comments have been addressed, the major remaining concern is about the placement of MIG-15 in the PLX-1 pathway. The data supporting the notion that MIG-15 is downstream of PLX-1 are weak. While this issue is addressed in part in Figure 8, the manuscript should be revised to address this concern. Specifically, the manuscript should overtly state the limitations of the genetic and phenotypic analyses and only speculate about the mechanistic relationship between MIG-15 and PLX-1.

We agree with the reviewers' comments.

In the revised manuscript, we emphasized that our works revealed the genetic relationship between *mig-15* and *plx-1* by adding 'genetically' in the following sentences.

Abstract:

"Here, we show that Rap2 GTPase (*rap-2*) and its effector, TNIK (*mig-15*), act genetically downstream of Plexin (*plx-1*) to restrict presynaptic assembly and form tiled synaptic innervation in *C. elegans*."

Introduction:

"Here, we report that *rap-2*, a *C. elegans* ortholog of human Rap2A, and its effector kinase *mig-15* (TNIK: *[Traf2]{.ul}*- and [N]{.ul}ck-[i]{.ul}nteracting [k]{.ul}inase) act genetically downstream of PLX-1 to regulate synaptic tiling."

In the following sentence, *rap-2* was replaced to *plx-1* as we did not show that *mig-15* acts downstream of *rap-2* in synaptic tiling.

Discussion section:

"We showed that proper synapse patterning requires both GDP- and GTP-forms of RAP-2. Considering that PLX-1 regulates the spatial distribution of RAP-2 activity and *mig-15* acts genetically downstream of *plx-1* in synaptic tiling, RAP-2 may also locally regulate MIG-15 (TNIK)."

The following sentences were added to describe the limitation of our analyses and the needs of future biochemical analysis to fully understand the mechanisms of PLX-1/Rap2/TNIK signaling in synapse pattern formation.

Discussion section:

"Due to the pleiotropic phenotype of the *mig-15* mutants, our genetic and phenotypic analyses of *mig-15* did not exquisitely reveal the mechanistic relationship between PLX-1 and MIG-15 in synaptic tiling regulation. Further biochemical studies of MIG-15 regulation by Plexin/Rap2 in synaptic tiling will elucidate the molecular mechanisms that underlie the role of MIG-15/TNIK in synapse pattern formation."

[^1]: These authors contributed equally to this work.
